Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.800
+0.004 (0.44%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Pasithea Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 18 | 4 | 8 | 19 | 39 | - |
| Market Cap Growth | 980.49% | -48.26% | -58.92% | -51.55% | - | - |
| Enterprise Value | 14 | -5 | -11 | -23 | 18 | - |
| Last Close Price | 0.80 | 3.15 | 7.40 | 12.83 | 35.40 | - |
| PS Ratio | - | - | - | - | 2572.20 | - |
| PB Ratio | 0.49 | 0.27 | 0.33 | 0.44 | 0.75 | - |
| P/TBV Ratio | 4.50 | 0.64 | 0.54 | 0.57 | 0.75 | - |
| EV/Sales Ratio | - | - | - | - | 1206.82 | - |
| Debt / Equity Ratio | - | - | 0.00 | 0.01 | - | - |
| Net Debt / Equity Ratio | -0.34 | -0.47 | -0.69 | -0.77 | -1.03 | -1.01 |
| Net Debt / EBITDA Ratio | 0.31 | 0.51 | 1.06 | 2.59 | 11.76 | - |
| Net Debt / FCF Ratio | 0.34 | 0.50 | 1.21 | 2.36 | 16.58 | 4.20 |
| Asset Turnover | - | - | - | - | 0.00 | - |
| Quick Ratio | 2.99 | 6.18 | 6.22 | 17.62 | 118.42 | 36.90 |
| Current Ratio | 4.01 | 6.58 | 6.34 | 18.15 | 119.17 | 37.55 |
| Return on Equity (ROE) | -89.90% | -72.84% | -47.07% | -24.97% | -8.41% | - |
| Return on Assets (ROA) | -53.70% | -42.23% | -28.02% | -15.98% | -10.52% | - |
| Return on Capital Employed (ROCE) | -113.10% | -95.40% | -68.00% | -29.10% | -8.50% | -25.50% |
| Earnings Yield | -73.05% | -348.55% | -207.04% | -74.25% | -5.61% | - |
| FCF Yield | -66.36% | -349.02% | -174.58% | -73.52% | -8.25% | - |
| Buyback Yield / Dilution | -298.39% | 10.64% | 2.83% | -142.65% | -41.29% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.